Generalized vitiligo after lymphocyte infusion for relapsed leukaemia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11899125.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vitiligo is an autoimmune disease caused by T-lymphocyte-mediated destruction of melanocytes. We describe two patients with generalized vitiligo caused iatrogenically after donor lymphocyte infusion (DLI) for leukaemia relapse over 3 years after bone marrow transplantation (BMT). Neither the sibling donor nor the recipient had vitiligo or other autoimmune diseases, and vitiligo did not occur after the first BMT. DLI was accompanied by skin graft-versus-host disease in both cases, which was controlled with immunosuppression. However, over several months, progressive generalized and persistent skin depigmentation occurred in both patients. Peripheral blood molecular studies showed the complete disappearance of host haematolymphopoiesis. The specific destruction of melanocytes in both patients was therefore probably mediated by new alloreactive lymphocytes infused from the donors.
Medical subject headings
- Autoimmune Diseases
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lymphocyte Transfusion
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Vitiligo